AC
LLY icon

AlphaCore Capital’s Eli Lilly LLY Stock Holding History

AlphaCore Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Buy
13,692
+7,852
+134% +$8.02M 0.3% 81
2026
Q1 		$5.37M Sell
5,840
-1,443
-20% -$1.46M 0.13% 148
2025
Q4 		$7.83M Buy
7,283
+676
+10% +$646K 0.17% 116
2025
Q3 		$5.04M Buy
6,607
+498
+8% +$371K 0.17% 114
2025
Q2 		$4.76M Buy
6,109
+2,778
+83% +$2.16M 0.18% 104
2025
Q1 		$2.75M Buy
3,331
+1,431
+75% +$1.19M 0.23% 90
2024
Q4 		$1.47M Buy
1,900
+287
+18% +$238K 0.32% 58
2024
Q3 		$1.43M Sell
1,613
-32
-2% -$28.8K 0.32% 59
2024
Q2 		$1.49M Buy
1,645
+572
+53% +$458K 0.36% 49
2024
Q1 		$835K Buy
1,073
+294
+38% +$209K 0.22% 68
2023
Q4 		$454K Buy
779
+102
+15% +$59.5K 0.07% 154
2023
Q3 		$364K Buy
677
+10
+1% +$5.15K 0.06% 169
2023
Q2 		$313K Buy
+667
New +$280K 0.05% 169
2020
Q2 		– Sell
-95
Closed -$13K – 202
2020
Q1 		$13K Buy
+95
New +$13.1K 0.01% 190

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaCore Capital's LLY Position: Q2 2026 in Review

AlphaCore Capital increased its Eli Lilly (LLY) stake by 134% in Q2 2026, buying an estimated $8.02M and bringing the position to 13,692 shares worth $16.4M. The position accounts for 0.3% of the portfolio, ranked #81.

AlphaCore Capital first reported a position in LLY in Q1 2020 and has held it in 14 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • AlphaCore Capital held 13,692 shares of Eli Lilly worth $16.4M as of Q2 2026.
  • AlphaCore Capital bought 7,852 Eli Lilly shares in Q2 2026, an estimated $8.02M.
  • Eli Lilly made up 0.3% of AlphaCore Capital's portfolio in Q2 2026, its #81 holding.
  • AlphaCore Capital first reported a position in Eli Lilly in Q1 2020 and has held it in 14 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.